Unichem Pharmaceuticals (USA), Inc. markets its own label generic pharmaceutical products in the United States.
Unichem Pharmaceuticals (USA), Inc. markets its own label generic pharmaceutical products in the United States. Our focus is on providing quality and cost effective products with reliable and effcient customer service. We market a growing list of US FDA approvaed procidts and have a strong product pipelemt to support our ambitious growth plans. We have a diversified range of formulation products that covers the therapeutic areas such as cardiology, pain management and psychiatry among others.
Unichem Pharmaceuticals (USA), Inc. is a wholly owned subsidiary of Unichem Laboratories Limited. Umichem Laboratories Limited together with its wholly owned subsidiaries is one of the leading vertically integrated pharmaceutical companies with presence in several countries.
Over the years, Unichem has invested significantly in its Research and Development (R&D) and manufacturing facilities. Unichem's expanded R&D and manufacturing facilities have further strengthened its API and Formulation capabilties.
Unichem's world-class drug kmanufacturing faciltieis are its greatest assets. With stringent quality controls and uncompromising environmental standards, Unichem's manufacturing facilties are geared to consistently deliver quality products.
Unichem is fully comitted to provide consistent supply levels and efficeient customer service. From the R&D and manufacturing of the active pharmaceutical ingredients and formulations to the markeing and distribution of the finished products, Unichem covers the full spectrum of supply chain.
Quality, Service and Reliability continue to be the three pillars of our success.
For more information, visit http://www.unichemusa.com.